Le Lézard
Classified in: Tourism and vacations, Health, Business, Covid-19 virus
Subject: PDT

COVID-19 Screening for Luxury Home Rentals Staff and Contractors in a Regional First


DUBAI, UAE, June 4, 2020 /PRNewswire/ -- As countries are slowly re-opening and returning to a 'new normal', Dubai-based hospitality firm Maison Privee is the first to implement a mandatory COVID-19 test program for all employees and suppliers. All guest facing staff and contractors working with the firm will be required to undergo testing using the COVID-19 IgM Rapid Testing Kit.

"The health and safety of guests is our number one priority. That's why we are rolling out a screening program to ensure that staff who interact with guests are regularly tested for COVID-19," said Rami Shamaa, Co-Founder and Managing Director. "We will also extend this mandatory testing to contractors who carry out cleaning or maintenance work in any Maison Privee properties," Mr Shamaa continued.

The Hecin COVID-19 IgM Antibody Rapid Test Kit is an immunochromatographic assay for rapid, qualitative detection of COVID-19 IgM Antibody in human whole blood, serum, plasma and fingertip blood sample. The test is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by 2019-nCoV. It will be used alongside other precautionary measures including temperature checks, use of PPE and social distancing to protect staff and guests.

"Having a suite of measures, including rapid COVID-19 diagnostics, to ensure the health and safety of employees and staff is a regional first and we are very proud that Maison Privee is taking the lead on this in our industry," said Paul Mallee, Co-Founder and Managing Director.

These policies come as a welcome initiative representing the first use of such tests in Dubai's hospitality industry. According to the World Health Organization (WHO), testing is the best way to monitor and manage the pandemic until an effective coronavirus vaccine becomes available.

Other measures implemented by the company include a requirement for certification of all cleaning contractors by Dubai Municipality's Health & Safety Department. "All surfaces are thoroughly disinfected including all touch-points, such as light switches, remotes, door handles and kitchen utensils. It's very important that our guests feel safe staying with us, knowing that we're doing everything possible to reduce their risk of infection," says Mr Mallee.

About Maison Privee

Maison Privee is a rapidly growing short term property rental company, based in Dubai. Founded in 2017 by Rami Shamaa and Paul Mallee, Maison Privee is a hospitality company providing vacation and corporate rentals in Dubai that combine the service and convenience of a premium hotel with the privacy and comfort of home.

In April 2018, Maison Privee closed a Series A funding round at USD $4,000,000 and are now rapidly expanding their portfolio of properties.

Maison Privee hand pick luxury properties in the best locations and support them with extensive services to ensure that guests have the best possible experience with every stay.

Maison Privee is licensed by Dubai Department of Tourism Commerce & Marketing (DTCM) to register and manage properties.

themaisonprivee.com

 

 

SOURCE Maison Privee


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: